Previous Close | 1.3400 |
Open | 1.3100 |
Bid | 1.3100 x 1000 |
Ask | 1.3500 x 1800 |
Day's Range | 1.3100 - 1.3900 |
52 Week Range | 0.8800 - 5.9900 |
Volume | |
Avg. Volume | 4,481,741 |
Market Cap | 31.144M |
Beta (5Y Monthly) | N/A |
PE Ratio (TTM) | N/A |
EPS (TTM) | -0.6110 |
Earnings Date | Nov 07, 2022 - Nov 11, 2022 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | 7.00 |
Subscribe to Yahoo Finance Plus to view Fair Value for AEMD
In this article, we will look at 10 healthcare and biotech stocks to buy amid the monkeypox threat. If you want to explore similar healthcare and biotech stocks, you can also take a look at 5 Healthcare and Biotech Stocks to Buy Amid Monkeypox Threat. In May of 2022, the first case of the monkeypox […]
Aethlon Medical Inc (NASDAQ: AEMD) said it is commissioning a new in vitro binding experiment to confirm that the Hemopurifier effectively captures the current strain of the monkeypox virus. The Hemopurifier is an extracorporeal (i.e., outside of the body) blood filtration device designed to selectively remove harmful particles from the circulatory system using lectin affinity agents. In 2008, the company conducted an in vitro study demonstrating that the Hemopurifier effectively bound and remov
Aethlon Medical, Inc. (Nasdaq: AEMD), a medical therapeutic company focused on developing products to diagnose and treat cancer and life threatening infectious diseases, today reported financial results for its first quarter ended June 30, 2022 and provided an update on recent developments.